As of Oct 17
| -0.0032 / -1.17%|
The 1 analysts offering 12-month price forecasts for Mateon Therapeutics Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +641.02% increase from the last price of 0.27.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.